ArticleInternational journal of physiology, pathophysiology and pharmacology2015
Aralar plays a significant role in maintaining the survival and mitochondrial membrane potential of BV2 microglia.
Article in International journal of physiology, pathophysiology and pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NADH shuttles mediate the transfer of the reducing equivalents of cytosolic NADH into mitochondria. Increasing evidence has suggested that malate-aspartate shuttle (MAS), one of the two types of NADH shuttles, plays important roles in certain biological processes. Aralar/AGC1, a Ca(2+)-dependent aspartate-glutamate carrier on mitochondrial membrane, is a component of MAS. It has been reported that Aralar plays crucial roles in linking increased cytosolic Ca(2+) concentrations to enhanced mitochondrial energy metabolism of neurons under certain conditions, while the role of the carrier in cell survival remains unknown. In the current study, we tested our hypothesis that Aralar plays an important role in cell survival, using BV2 microglia as a cellular model. Our study showed that Aralar siRNA-produced decrease in the Aralar level led to a significant reduction of the cell survival. Our FACS-based Annexin V/7-AAD assays also showed that the Aralar siRNA treatment led to a significant increase in apoptosis of the cells. Moreover, the Aralar siRNA treatment led to both mitochondrial depolarization and decreases in the intracellular ATP level of the cells. Collectively, our study has provided the first evidence suggesting that Aralar plays a significant role in cell survival, at least for such cell types as BV2 microglia, possibly by producing mitochondrial depolarization. These observations have also provided novel information for understanding the roles of NADH shuttles in cell survival.
Indexed as
Identifiers
26330901PMC4550213W1444697690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.